David Wells
Analyst · Cleveland Research. Your line is open
Thanks, Neil, and good morning, everyone. Before we move on to cover further details on our most recent quarter financial performance, a reminder that the supplemental investor deck issued this morning recapping key financial and performance talking points is available for your reference on our investor site. Turning now to our second quarter results. Sales for the quarter ending December 2018 increased 25.9% over the prior year quarter with acquisitions driving a 21.3% year-over-year increase. Organically, sales grew 3.7%, while the impact of foreign currency exchange decreased sales by 0.7%. There was one extra selling day in this year's quarter, which generated a 1.6% benefit to reported organic growth. Second quarter sales in our service center based distribution segment increased by $33.7 million or 6.1% year-over-year. Excluding the adverse impact of foreign currency translation, sales increase by 6.9%. This includes a 1.6% benefit from one additional selling day in this year's quarter. As previously mentioned, in our service center based distribution segment, as well as our Fluid Power & Flow Control segment, we saw the adverse impact of 2018 holiday timing including reduced year-end shutdown maintenance activity. Overall, Applied organic sales growth was up nearly 6% through December 21, but finished up less than 1% for the month of December after the final week of the calendar year. Moving to our Fluid Power & Flow Control segment, second quarter sales increased $139.2 million or 124.7% as compared to the prior year. Acquisitions within this segment namely the addition of both FCX performance and more recently Fluid Power sales increased sales by 127.4%. Excluding the impact of acquisitions, sales were down $3 million or 2.7% as a 4.4% decline was partially offset by the 1.7% benefit of one additional selling day in the quarter. Our Fluid Power & Flow Control segment growth was down from recent quarters given the tougher year-over-year comps, timing of larger projects and lower demand from technology markets as well as some adverse impact of supplier performance. Excluding FCX and the most recent Fluid Power sales acquisition, the legacy Fluid Power organic backlog at quarter end remained strong with a further modest increase to backlog in the quarter. From a geographic perspective, sales in the quarter for our U.S operations were up $170.2 million or 30.5% year-over-year with acquisitions driving $142.2 million or 25.5% of this increase. Excluding acquisition impact, organic sales growth from U.S operations reflected a 5% increase, which included a 1.6% benefit from the extra sales day in this year's quarter. Sales from our businesses outside of the United States grew 6.7% organically with solid performance across all geographies. The extra sales day in this year's quarter drove 1.7% of this growth. Foreign currency impact, however, was a 4.3% headwind resulting in a reported 2.4% sales increase in our foreign markets as compared to the prior year quarter. Moving on to gross margins. Our gross profit percentage for the quarter was 28.9%, up 68 basis points year-over-year. Acquisitions drove 93 basis points of margin expansion year-over-year. Excluding this accretive benefit, gross profit margin for the core business was 28%, 26 basis points lower than prior year, driven by an increase in purchase costs in the quarter. This inflationary impact generated a $2.7 million non-cash LIFO inventory charge for the quarter, which represented a 32 basis point headwind for the quarter and a 16 basis point adverse year-over-year impact. This equates to a $0.05 per share adverse EPS impact. We expect margins to normalize in Q3 as we pass on the recent supplier price increases. Our selling, distribution and administrative expenses on an absolute basis increased $40.3 million or 28.4% when compared to the same quarter in the prior year. Acquired businesses accounted for $36.4 million or 25.7% of year-over-year SG&A growth, while fluctuations in foreign currency rates decreased SG&A for the quarter by .8% compared to the prior year quarter. Excluding the impact of acquisitions, the nominal 2.7% year-over-year increase in SG&A expense included a 120 basis point increase in our self-insured medical costs attributed to several major medical cases, along with the impact of annual merit increases. The effective income tax rate was 23.2% for the quarter. Resulting EPS for the quarter was $0.99 per share, up 25.3% year-over-year. Excluding the benefit of lower effective tax rate, pre-tax income increased 13.1% year-over-year. Our consolidated balance sheet remains strong with shareholders' equity of $890 million, representing more than a 9% increase year-to-date. Cash generated from operating activities was $53.8 million for the quarter, which represents a $42 million improvement from the prior year quarter. Quarter results demonstrated continued traction generated by operating working capital management initiatives. We continue to extinguish the additional debt assumed to fund the FCX performance acquisition with net leverage based on our existing credit facility covenants now just over 2.8x EBITDA as of quarter end. In our first quarter, as previously communicated, we fully extinguished $112.5 million initial draw taken on our $250 million revolving credit line to fund the FCX acquisition. There was no utilization of our revolving credit line in the most recent quarter. As noted in our press release, today we announced that our Board of Directors raised the quarterly cash dividend to $031 per common share. This represents the 10th dividend increase since 2010 and underscores our strong cash generation and commitments delivering shareholder value. To recap, while our second quarter performance reflects some of the inflationary impact and economic conditions, which have played out in recent quarter, we remain focused on continued execution of our strategic priorities in any environment. EBITDA for the quarter was $76 million or 9.1% of sales, a 58 basis point improvement and we generated strong cash flow in the quarter. Our Fluid Power & Flow Control segment backlog position remains strong and we continue to see broad based opportunities for growth in all businesses and geographies. As we neared the one-year anniversary of the FCX performance acquisition, we remain pleased with the contributions of the business. FCX contributed another $0.06 per share to year-over-year growth in earnings per share in the quarter. Transitioning now to our revised outlook given the current moderate industrial environment and business conditions, we're revising our full-year fiscal 2019 sales and earnings per share guidance to between $4.45 and $4.65 per share on a sales increase of 12.5% to 15% with full-year sales from our legacy operations forecast to be in the range of up 2% to up 3% year-over-year. While showing a softer top line, our guidance still assumes a 2% to 4% step up in daily sales rates second half versus first half, excluding the benefit from the recent FPS acquisition. We're assuming second half Fluid Power & Flow Control daily sales rates remain essentially consistent with what we saw in the first half and a 3% to 5% increase in second half daily sales rates in our service center segment. This would generate 4% to 6% second half organic growth in our service center segment with a 5% to 7% sales decline in our legacy Fluid Power business, given continued tech driven softness and tougher second half comps. Additionally, our guidance assumes a 15 to 30 basis point step up in second half margin performance, driven by pricing and other margin expansion initiatives. SG&A and interest expense favorability will partially offset the adverse impact of lower top line. With that, I will now turn the call back over to Neil for some final comments.